Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.

about

Preference-based valuation of treatment attributes in haemophilia A using web survey.

P2860

Q45871318-8CFE1668-5848-406A-BD0B-C6F18EA8295F

P2860

Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.

Item

http://www.wikidata.org/entity/Q39791634

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Preferences for improvements i ...... diabetic population in Sweden.

@en

Preferences for improvements i ...... diabetic population in Sweden.

@nl

type

Item

label

Preferences for improvements i ...... diabetic population in Sweden.

@en

Preferences for improvements i ...... diabetic population in Sweden.

@nl

prefLabel

Preferences for improvements i ...... diabetic population in Sweden.

@en

Preferences for improvements i ...... diabetic population in Sweden.

@nl

P1476

Preferences for improvements i ...... diabetic population in Sweden.

@en

P2093

Hanna Norrlid

http://www.w3.org/2001/XMLSchema#string

Sara Olofsson

http://www.w3.org/2001/XMLSchema#string

Ulf Persson

http://www.w3.org/2001/XMLSchema#string

P2860

Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data.

Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit.

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes.

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes.

Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom.

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month e

Addressing barriers to initiation of insulin in patients with type 2 diabetes.

P304

945-958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13696998.2016.1187152

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27149402

http://www.w3.org/2001/XMLSchema#string

P921

An t-Suain

Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.

about

P2860

P2860

Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921